IDL Biotech AB (IDL Biotech) is a pharmaceutical company that develops, manufactures and commercializes vitro diagnostic tests. It develops products in the clinical areas of oncology and bacteriology. It provides vitro diagnostic tumor activity markers for common types of cancer that includes breast, colorectal, lung, ovarian and prostate cancer. IDL Biotech offers serum and urine analysis to measure disease status in patients. It also manufactures rapid Salmonella typhoid test. The company works in partnership with various companies across Africa, Asia, Central America, Europe, North America and South America. It offers its products for healthcare industry globally. IDL Biotech is headquartered in Bromma, Sweden.
This comprehensive SWOT profile of IDL Biotech AB provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of IDL Biotech AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1-About the Company
IDL Biotech AB-Key Information
IDL Biotech AB-Overview
IDL Biotech AB-Key Employees
IDL Biotech AB-Key Employee Biographies
IDL Biotech AB-Key Operational Heads
IDL Biotech AB-Major Products and Services
IDL Biotech AB-History
IDL Biotech AB-Company Statement
IDL Biotech AB-Locations And Subsidiaries
IDL Biotech AB-Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2-Company Analysis
IDL Biotech AB-Business Description
IDL Biotech AB-Corporate Strategy
IDL Biotech AB-SWOT Analysis
IDL Biotech AB-Strengths
IDL Biotech AB-Weaknesses
IDL Biotech AB-Opportunities
IDL Biotech AB-Threats
IDL Biotech AB-Key Competitors
Section 3-Company Financial Performance Charts
IDL Biotech AB-Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Note*: Some sections may be missing if data is unavailable for the company
List of Figures
IDL Biotech AB, Performance Chart
IDL Biotech AB, Ratio Charts
List of Tables
IDL Biotech AB, Key Information
IDL Biotech AB, Key Ratios
IDL Biotech AB, Share Data
IDL Biotech AB, Major Products and Services
IDL Biotech AB, History
IDL Biotech AB, Key Employees
IDL Biotech AB, Key Employee Biographies
IDL Biotech AB, Key Operational Heads
IDL Biotech AB, Other Locations
IDL Biotech AB, Subsidiaries
IDL Biotech AB, Key Manufacturing facilities
IDL Biotech AB, Key Competitors
IDL Biotech AB, SWOT Analysis
IDL Biotech AB, Ratios based on current share price
IDL Biotech AB, Annual Ratios
IDL Biotech AB, Interim Ratios
Capital Market Ratios
Single User License:
Corporate User License:
IDL Biotech AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
select a license
NEWSLETTER BY CATEGORY
An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ... "General Manager SBU Manufacture, PT. KIMIA FARMA, TBK"
Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process.... "VP Innovation, Engineered Profiles LLC"
Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed... "President, VPP E-Data Services, VPP E-Data Services"
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"